In addition, at the 5- and 3-end, a human elongation factor-1 promoter and a cisacting hepatitis delta virus ribozyme following poly-A, were added, respectively.
In addition, at the 5- and 3-end, a human elongation factor-1 promoter and a cisactinghepatitis delta virus ribozyme following poly-A, were added, respectively.